When the time came for the Florida-based biotech company AxoGen to expand, “we went into a lot of communities,” looking for the best fit in which to locate their new distribution center, AxoGen CEO Karen Zaderej said this week.
But, she said, when the company representatives found Burleson and started talking with city officials, “the choice became a very easy one to make.”
The company held grand opening ceremonies, including a ribbon cutting and an open house, for its new distribution center, at 300 Boone Road in Burleson, on Monday.
AxoGen’s corporate headquarters are in Alachua, Fla., and it has research and development facilities in Virginia Beach, Va. But, Zaderej said, without a presence further west, the company was hitting some roadblocks in distribution,
AxoGen’s products, Zaderej said, are often used in emergency procedures to treat traumatic injuries involving peripheral nerve damage. When the company gets a call late in the day from the west coast for product needed for surgical procedures the following day, it is often too late for AxoGen to get the product shipped in time because of the time difference.
That’s why they started looking for a new distribution center location, Zaderej said. Burleson, she said, had a lot of advantages that were immediately obvious. It is centrally located in the country, and it is located near major transportation hubs.
The city also offered a well-trained and well-educated work force.
“In the medical field, you can’t make mistakes,” Zaderej said. “So having that well-educated work force capable of doing the kind of work we need them to do was vital.”
But it was the city staff that really made the difference.
“When we came to Burleson and started looking, we found the town to be very welcoming, and the city staff here was great to work with,” Zaderej said. “And that made all the difference for us. That’s what really swung it for us.”